Company Profiles

driven by the PitchBook Platform

AltaThera Pharmaceuticals

AltaThera Pharmaceuticals
2012 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Angel LATEST DEAL TYPE
$3.58M LATEST DEAL AMOUNT
$6.08M TOTAL AMOUNT RAISED
Description

Operator of a specialty pharmaceutical company. The company is focused on identifying, acquiring, developing, & commercializing therapies for unmet medical needs of critical care patients & those with severe, often rare, disorders for which few effective treatments are available.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
200 South Wacker Drive
Suite 3100
Chicago, IL 60606
United States

+1 (312) 445-8900
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AltaThera Pharmaceuticals’s full profile, request a free trial.

AltaThera Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 22-Dec-2016 $3.58M $6.08M Completed Startup
3. Angel (individual) 31-Jul-2015 000 00.00 Completed Startup
2. Angel (individual) 03-Feb-2015 $1.5M $1.5M Completed Startup
1. Accelerator/Incubator 28-Oct-2014 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

AltaThera Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Matter Ventures Accelerator/Incubator 000 0000 000000 0

AltaThera Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Brandon Kashfian President, Board Member & Chief Executive Officer
Stephen O'Sullivan JD Chief Compliance Officer, Board Member & General Counsel
John Flavin Executive Chairman

AltaThera Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
John Flavin AltaThera Pharmaceuticals Executive Chairman 000 0000